Frankfurt - Delayed Quote EUR

IRADIMED CORPORATION (46K.F)

45.80

+0.40

+(0.88%)

As of April 15 at 8:05:42 AM GMT+2. Market Open.

Undiscovered Gems in the US Market for April 2025

As the U.S. market navigates a landscape marked by tariff tensions and economic uncertainties, major indices like the Dow Jones Industrial Average are experiencing volatility, yet remain poised for potential weekly gains. In this climate of fluctuating investor sentiment and economic indicators, identifying promising small-cap stocks requires a keen eye for companies with strong fundamentals and resilience to macroeconomic pressures.

Simply Wall St. 4 days ago

TILE

IRMD

UVSP
Here's Why We Think IRADIMED (NASDAQ:IRMD) Is Well Worth Watching

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Simply Wall St. 16 days ago

IRMD
Undiscovered Gems in the US Market for March 2025

Over the last 7 days, the United States market has experienced a 4.4% drop, yet it remains up by 7.5% over the past year with earnings forecasted to grow by 14% annually. In this dynamic environment, identifying stocks that are not only resilient but also positioned for growth can be crucial for investors seeking to uncover hidden opportunities in the market.

Simply Wall St. last month

IRMD

UNTY

EZPW
IRADIMED CORPORATION To Participate at the 37th Annual Roth Conference

WINTER SPRINGS, Fla., March 10, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that it will participate in the 37th Annual Roth Conference. Iradimed’s CFO, Jack Glenn, and CCO, Jeff Chiprin, will host one-on-one meetings between company management and investors at the 37th Annual Roth Conference, which will be held at the Laguna Cliffs Marriott in Dana Point, CA, on March 17 and 18, 2025. About IRADIMED CORPORATION IRADIMED CORPORATION is a leader in

GlobeNewswire last month

IRMD
Is Weakness In IRADIMED CORPORATION (NASDAQ:IRMD) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

It is hard to get excited after looking at IRADIMED's (NASDAQ:IRMD) recent performance, when its stock has declined...

Simply Wall St. last month

IRMD
Earnings Update: Here's Why Analysts Just Lifted Their IRADIMED CORPORATION (NASDAQ:IRMD) Price Target To US$71.00

IRADIMED CORPORATION ( NASDAQ:IRMD ) shareholders are probably feeling a little disappointed, since its shares fell...

Simply Wall St. last month

IRMD
Q4 2024 IRadimed Corp Earnings Call

Q4 2024 IRadimed Corp Earnings Call

Thomson Reuters StreetEvents last month

IRMD
iRadimed Corp (IRMD) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Shifts

iRadimed Corp (IRMD) reports its 14th consecutive record quarter with strong domestic sales and strategic focus on monitor business for 2025.

GuruFocus.com last month

IRMD
IRadimed (IRMD) Lags Q4 Earnings Estimates

iRadimed (IRMD) delivered earnings and revenue surprises of -2.22% and 1.57%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks last month

IRMD
IRadimed: Q4 Earnings Snapshot

Earnings, adjusted for stock option expense, were 44 cents per share. The maker of IV devices that can be used in MRI machines posted revenue of $19.4 million in the period. For the year, the company reported profit of $19.2 million, or $1.50 per share.

Associated Press Finance last month

IRMD
IRADIMED CORPORATION Announces Fourth Quarter and Full Year of 2024 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.17 Per Share from $0.15 Per Share

Reports record revenue of $19.4 million for the fourth quarter of 2024, an increase of $1.9 million or 11%, compared to the same period in 2023. Reports GAAP diluted EPS of $0.40 and non-GAAP diluted EPS of $0.44 for the fourth quarter of 2024.Reports GAAP diluted EPS of $1.50 and non-GAAP diluted EPS of $1.66 for the full year of 2024.Declares a regular quarterly cash dividend of $0.17 per common share for the first quarter of 2025, payable on March 5, 2025. WINTER SPRINGS, Fla., Feb. 13, 2025

GlobeNewswire last month

IRMD
Waters (WAT) Q4 Earnings and Revenues Top Estimates

Waters (WAT) delivered earnings and revenue surprises of 1.99% and 1.82%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 2 months ago

IRMD
Three Undiscovered Gems in the US Stock Market

Over the last 7 days, the United States stock market has remained flat, yet it boasts a remarkable 22% increase over the past year with earnings forecasted to grow by 15% annually. In this dynamic environment, identifying stocks that have not yet captured widespread attention but possess strong growth potential can be key to uncovering hidden opportunities.

Simply Wall St. 2 months ago

AUDC

IRMD

AGX
IRADIMED CORPORATION to Hold Fourth Quarter of 2024, Full Year of 2024 Financial Results Conference Call on February 13, 2025

WINTER SPRINGS, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 fourth quarter financial results before the market opens on Thursday, February 13, 2025. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions. Individuals interested in participating in the conference call may do so by registering here, https://register.veven

GlobeNewswire 2 months ago

IRMD
IRADIMED's (NASDAQ:IRMD) investors will be pleased with their solid 156% return over the last five years

When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...

Simply Wall St. 2 months ago

IRMD
IRADIMED CORPORATION Reports Preliminary Unaudited Record Fourth Quarter and Full-Year 2024 Revenues

Reports preliminary fourth quarter 2024 revenue in the range of approximately $19.2 million to $19.4 millionReports preliminary full-year 2024 revenue in the range of approximately $73.1 million to $73.3 millionIradimed is scheduled to present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15th, 2025, at 5:15 p.m. PT WINTER SPRINGS, Fla., Jan. 10, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company” or “Iradimed”) (NASDAQ: IRMD), a leader in developing innovative Magneti

GlobeNewswire 3 months ago

IRMD
Discovering Undiscovered Gems with Strong Potential This December 2024

In the last week, the United States market has remained flat, yet it has achieved a remarkable 24% increase over the past year with earnings projected to grow by 15% annually in the coming years. In this dynamic environment, identifying stocks with strong potential involves seeking out companies that are not only resilient but also poised to capitalize on these favorable growth trends.

Simply Wall St. 3 months ago

PRDO

IRMD

PLAB
IRADIMED CORPORATION to Present at the 43rd Annual J.P. Morgan Healthcare Conference

WINTER SPRINGS, Fla., Dec. 19, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), a leading provider of innovative magnetic resonance imaging (“MRI”) compatible medical devices and the only provider of a non-magnetic intravenous (“IV”) infusion pump system announced today that Roger Susi, Chief Executive Officer and Jack Glenn, Chief Financial Officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference. The Company presentation will take place on Wednesd

GlobeNewswire 3 months ago

IRMD
Should You Investigate IRADIMED CORPORATION (NASDAQ:IRMD) At US$54.43?

While IRADIMED CORPORATION ( NASDAQ:IRMD ) might not have the largest market cap around , it led the NASDAQGM gainers...

Simply Wall St. 3 months ago

IRMD
IRADIMED CORPORATION on Forbes’ List of America’s Most Successful Small-Cap Companies for 2025

WINTER SPRINGS, Fla., Dec. 10, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), today announced it has been ranked 24th on Forbes’ list of America’s Most Successful Small-Cap Companies 2025. Iradimed is a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only provider of a non-magnetic intravenous (“IV”) infusion pump system and non-magnetic patient vital signs monitoring systems that are designed for use during MRI pr

GlobeNewswire 4 months ago

IRMD

Performance Overview

Return	46K.F	S&P 500 (^GSPC)
YTD	-9.91%	-8.25%
1-Year	+21.55%	+6.61%
3-Year	+19.73%	+22.86%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

IRADIMED CORPORATION (46K.F)

Undiscovered Gems in the US Market for April 2025

Here's Why We Think IRADIMED (NASDAQ:IRMD) Is Well Worth Watching

Undiscovered Gems in the US Market for March 2025

IRADIMED CORPORATION To Participate at the 37th Annual Roth Conference

Is Weakness In IRADIMED CORPORATION (NASDAQ:IRMD) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Earnings Update: Here's Why Analysts Just Lifted Their IRADIMED CORPORATION (NASDAQ:IRMD) Price Target To US$71.00

Q4 2024 IRadimed Corp Earnings Call

iRadimed Corp (IRMD) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Shifts

IRadimed (IRMD) Lags Q4 Earnings Estimates

IRadimed: Q4 Earnings Snapshot

IRADIMED CORPORATION Announces Fourth Quarter and Full Year of 2024 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.17 Per Share from $0.15 Per Share

Waters (WAT) Q4 Earnings and Revenues Top Estimates

Three Undiscovered Gems in the US Stock Market

IRADIMED CORPORATION to Hold Fourth Quarter of 2024, Full Year of 2024 Financial Results Conference Call on February 13, 2025

IRADIMED's (NASDAQ:IRMD) investors will be pleased with their solid 156% return over the last five years

IRADIMED CORPORATION Reports Preliminary Unaudited Record Fourth Quarter and Full-Year 2024 Revenues

Discovering Undiscovered Gems with Strong Potential This December 2024

IRADIMED CORPORATION to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Should You Investigate IRADIMED CORPORATION (NASDAQ:IRMD) At US$54.43?

IRADIMED CORPORATION on Forbes’ List of America’s Most Successful Small-Cap Companies for 2025

Performance Overview